Skip to content

Role of Endoscopic Third Ventriculostomy in Management of Malfunctioning Ventriculoperitoneal Shunt

Role of Endoscopic Third Ventriculostomy in Management of Malfunctioning Ventriculoperitoneal Shunt

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06341946
Enrollment
30
Registered
2024-04-02
Start date
2024-04-05
Completion date
2025-11-30
Last updated
2024-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hydrocephalus, Shunt Malfunction

Keywords

endoscopic third ventriculostomy

Brief summary

The aim of this study is to analyze our experience in management of malfunctioning ventriculoperitoneal shunt by using endoscopic third ventriculostomy (ETV).

Detailed description

Cerebrospinal fluid shunting remains the most common line of treatment for hydrocephalus. Endoscopic third ventriculostomy (ETV) is an alternative to cerebrospinal fluid (CSF) shunting that is potentially favorable due to the lack of implanted hardware. Most previous studies of ETV have focused on its role as an initial treatment for hydrocephalus and on comparing ETV with CSF shunting. However ,some patients who have previously been treated with a CSF shunt then developed malfunction are candidate for ETV. The ETV Success Score (ETVSS) is the most widely used scale to estimate the likelihood of ETV success for a given patient . Although the age of the patient is the most important component of the ETVSS, history of previous treatment with a shunt is also included in the model. According to the ETVSS, previous shunting reduces the likelihood of ETV success by approximately 10%. There have been numerous previous studies of ETV in patients with a history of a CSF shunt (post shunt ETV), reporting success rates from 50% to 80% . Two review articles also covered this topic, one of which reported ETV success by meta-analysis in 68% of 519 pooled patients . Most patients with shunt malfunction and or infection are treated with revision procedures, but ETV can be used as an alternative treatment in such cases .The role of endoscopic management of hydrocephalus in shunt malfunction was not investigated extensively so far. There are several studies which have considered ETV as the main treatment of hydrocephalus inpatients with shunt failure. Therefore, this is an attractive topic in neurosurgery especially in pediatric neurosurgery that can work and make a different kind of studies to explore the role of ETV for shunt failure. The goal of the current study was to present our experience with endoscopic third ventriculostomy for management of shunt malfunction.

Interventions

role of endoscopic third ventriculostomy in management of malfunctioning ventriculoperitoneal shunt

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

All patients with malfunctioning VP shunt will be included in this study

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* • All patients with malfunctioning VP shunt will be included in this study.

Exclusion criteria

* Patients with contraindications for endoscopic procedure such as intracranial infection or bleeding disorders * Previous unsuccessful attempts of endoscopic third ventriculostomy. * Active infection or inflammation in the central nervous system. * Recent history of intracranial hemorrhage. * Medically unfit for surgery.

Design outcomes

Primary

MeasureTime frameDescription
Glasgow Coma Scale (GCS)base lineclinical symptoms improvement this Score has values between 3 and 15, 3 being the worst and 15 being the highest
visual analogue scale( VAS )base lineclinical symptoms improvement this Score has values between 0 and 10, 0 being the best and 10 being the worst
visual acuitybase lineclinical symptoms improvement

Secondary

MeasureTime frameDescription
radiological CT brain and or MRI brainbase lineCT brain and or MRI brain

Contacts

Primary ContactOmar Mahmoud Abellah, M.B.B. Ch, M.Sc
omr.hassan@med.sohag.edu.eg01114514558
Backup ContactRoshdy Abdelaziz Elkahyat, MD, Professor of Neurosurgery
roushdy.elkhayat@med.aun.edu.eg01223486390

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026